Development of novel azabenzofuran TRPA1 antagonists as in vivo tools

Compound 10 provides an unbound plasma concentration 16-fold in excess of the in vitro TRPA1 IC50 and demonstrates significant effect in an on-target biochemical challenge study (allyl isothiocyanate-induced flinching).